Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Wide-Ranging Analysis of MicroRNA Profiles in Sporadic Amyotrophic Lateral Sclerosis Using Next-Generation Sequencing
Bruna De Felice, Francesco Manfellotto, Giuseppe Fiorentino, et al.
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders
Kinga Czubowicz, Henryk Jęśko, P.L. Wencel, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5436-5455
Open Access | Times Cited: 232
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Prashanth Gowda, P. Hemachandra Reddy, Subodh Kumar
Ageing Research Reviews (2021) Vol. 73, pp. 101529-101529
Open Access | Times Cited: 104
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases
T. P. Nhung Nguyen, Mandeep Kumar, Ernesto Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4718-4718
Open Access | Times Cited: 51
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Giulia Gentile, Giovanna Morello, Valentina La Cognata, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 770-770
Open Access | Times Cited: 46
Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis
Metka Ravnik‐Glavač, Damjan Glavač
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1714-1714
Open Access | Times Cited: 60
Systematic review and meta-analysis on microRNAs in amyotrophic lateral sclerosis
Hua Liu, Shan Lan, Xiaojie Shi, et al.
Brain Research Bulletin (2023) Vol. 194, pp. 82-89
Open Access | Times Cited: 20
Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation
Narges Daneshafrooz, Mohammad Taghi Joghataei, Mehdi Mehdizadeh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
Mafalda Rizzuti, Valentina Melzi, Delia Gagliardi, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 24
Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis
Antonella Panio, Claudia Cava, Salvatore D’Antona, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 19
Circulating miR-223/NLRP3 axis and IL-1β level in functional disease progression of amyotrophic lateral sclerosis
Mitra Ansari Dezfouli, Davood Shalilahmadi, Gholamreza Shamsaei, et al.
Acta Neurologica Belgica (2025)
Closed Access
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis
Xiaotong Hou, JingSi Jiang, Min Deng
Journal of Neurology (2025) Vol. 272, Iss. 4
Closed Access
Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy
Jade Pham, Matt Keon, Samuel Brennan, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3464-3464
Open Access | Times Cited: 29
MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease
Bruna De Felice, Concetta Montanino, Mariano Oliva, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4408-4416
Open Access | Times Cited: 28
RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective
Pietro Laneve, Paolo Tollis, Elisa Caffarelli
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10285-10285
Open Access | Times Cited: 24
Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis
Orietta Pansarasa, Maria Garofalo, Eveljn Scarian, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2580-2580
Open Access | Times Cited: 18
Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives
Adelaida Hernaiz, Janne M. Toivonen, Rosa Bolea, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12609-12609
Open Access | Times Cited: 17
MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis
Marcela Alvia, Nurgül Aytan, Keith R. Spencer, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 16
Biological Significance of microRNA Biomarkers in ALS—Innocent Bystanders or Disease Culprits?
Sophie Foggin, Raquel Mesquita-Ribeiro, Federico Dajas‐Bailador, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 24
Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis
Ximena Paez-Colasante, Claudia Figueroa‐Romero, Amy E. Rumora, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 21
MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development
Lin Wang, Lijuan Zhang
Neurological Sciences (2020) Vol. 41, Iss. 12, pp. 3569-3577
Closed Access | Times Cited: 19
Biomolecular Modifications Linked to Oxidative Stress in Amyotrophic Lateral Sclerosis: Determining Promising Biomarkers Related to Oxidative Stress
Takashi Hosaka, Hiroshi Tsuji, Akira Tamaoka
Processes (2021) Vol. 9, Iss. 9, pp. 1667-1667
Open Access | Times Cited: 13
Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases
Juan Zhang, Zhu Chen, Hui Chen, et al.
Biosensors (2022) Vol. 12, Iss. 12, pp. 1074-1074
Open Access | Times Cited: 8
Opportunities Offered by Graphene Nanoparticles for MicroRNAs Delivery for Amyotrophic Lateral Sclerosis Treatment
Benedetta Niccolini, Valentina Palmieri, Marco De Spirito, et al.
Materials (2021) Vol. 15, Iss. 1, pp. 126-126
Open Access | Times Cited: 11
Differently expressed microRNA in response to the first Ig replacement therapy in common variable immunodeficiency patients
Bruna De Felice, Ersilia Nigro, Rita Polito, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Emerging role of microRNAs in the pathogenesis of amyotrophic lateral sclerosis
Nader Akbari Dilmaghani, Bashdar Mahmud Hussen, Saeedeh Nateghinia, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 5, pp. 737-749
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top